Global Medical Automatic Nucleic Acid Extractor Market Growth 2023-2029

Global Medical Automatic Nucleic Acid Extractor Market Growth 2023-2029

The automatic nucleic acid extractor is used in conjunction with supporting reagents for fully automatic extraction and purification of DNA/RNA, proteins and cells. The magnetic bead method is adopted to realize the transfer of magnetic beads/sample through the adsorption, transfer and release of magnetic beads by the magnetic rod and the magnetic rod sleeve, and complete the automatic extraction and purification operation. The operation is automated, fast and simple. Using a special kit or a 96-well reaction plate, 1 to 96 samples can be processed simultaneously. With different kinds of magnetic bead nucleic acid extraction reagents, it can be used for the extraction and purification of different nucleic acids in clinical samples.

LPI (LP Information)' newest research report, the “Medical Automatic Nucleic Acid Extractor Industry Forecast” looks at past sales and reviews total world Medical Automatic Nucleic Acid Extractor sales in 2022, providing a comprehensive analysis by region and market sector of projected Medical Automatic Nucleic Acid Extractor sales for 2023 through 2029. With Medical Automatic Nucleic Acid Extractor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Automatic Nucleic Acid Extractor industry.

This Insight Report provides a comprehensive analysis of the global Medical Automatic Nucleic Acid Extractor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Automatic Nucleic Acid Extractor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Medical Automatic Nucleic Acid Extractor market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Automatic Nucleic Acid Extractor and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Automatic Nucleic Acid Extractor.

The global Medical Automatic Nucleic Acid Extractor market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Medical Automatic Nucleic Acid Extractor is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Medical Automatic Nucleic Acid Extractor is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Medical Automatic Nucleic Acid Extractor is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Medical Automatic Nucleic Acid Extractor players cover Thermo Fisher Scientific, Inc., Illumina, Inc., Agilent Technologies, Inc., Tecan Group AG., Sigma Aldrich Corp., Becton Dickinson and Company, QIAGEN, Bio-Rad Laboratories Inc. and PerkinElmer, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Automatic Nucleic Acid Extractor market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Fully Automatic
Semi-automatic

Segmentation by application
Hospital
Nucleic Acid Diagnostic Institutions

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific, Inc.
Illumina, Inc.
Agilent Technologies, Inc.
Tecan Group AG.
Sigma Aldrich Corp.
Becton Dickinson and Company
QIAGEN
Bio-Rad Laboratories Inc.
PerkinElmer, Inc.
F. Hoffmann-La Roche
DiaSorin S.p.A
SHINHUA
Esco Micro Pte. Ltd.
Analytik Jena GmbH
Aurora

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Automatic Nucleic Acid Extractor market?

What factors are driving Medical Automatic Nucleic Acid Extractor market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical Automatic Nucleic Acid Extractor market opportunities vary by end market size?

How does Medical Automatic Nucleic Acid Extractor break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.